BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862
1051 results:

  • 1. FBXO32-mediated degradation of pten promotes lung adenocarcinoma progression.
    Wu J; Wen T; Marzio A; Song D; Chen S; Yang C; Zhao F; Zhang B; Zhao G; Ferri A; Cheng H; Ma J; Ren H; Chen QY; Yang Y; Qin S
    Cell Death Dis; 2024 Apr; 15(4):282. PubMed ID: 38643215
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Hibiscus manihot L. flower extract induces anticancer activity through modulation of apoptosis and autophagy in A549 cells.
    Xu M; Zhao M; Zhu M; Yuan H; Li Z; Yan P; Ma C; Zhao H; Wang S; Wan R; Wang L; Yu G
    Sci Rep; 2024 Apr; 14(1):8102. PubMed ID: 38582921
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. NDRG2 acts as a negative regulator of the progression of small-cell lung cancer through the modulation of the pten-AKT-mTOR signalling cascade.
    Ma Z; Ma Y; Feng J; Xu Z; Cheng C; Qin J; Li S; Jiang J; Kong R
    Toxicol Appl Pharmacol; 2024 Apr; 485():116915. PubMed ID: 38537875
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Scutellarin, a flavonoid compound from Scutellaria barbata, suppresses growth of breast cancer stem cells in vitro and in tumor-bearing mice.
    Ma H; Yue GG; Lee JK; Gao S; Yuen KK; Cheng W; Li X; Lau CB
    Phytomedicine; 2024 Jun; 128():155418. PubMed ID: 38518647
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. pten decreases NR2F1 expression to inhibit ciliogenesis during EGFR
    Tran TTT; Hung JJ
    Cell Death Dis; 2024 Mar; 15(3):225. PubMed ID: 38499532
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A SWI/SNF-dependent transcriptional regulation mediated by POU2AF2/C11orf53 at enhancer.
    Szczepanski A; Tsuboyama N; Lyu H; Wang P; Beytullahoglu O; Zhang T; Singer BD; Yue F; Zhao Z; Wang L
    Nat Commun; 2024 Mar; 15(1):2067. PubMed ID: 38453939
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expression.
    Cai H; Zhang B; Ahrenfeldt J; Joseph JV; Riedel M; Gao Z; Thomsen SK; Christensen DS; Bak RO; Hager H; Vendelbo MH; Gao X; Birkbak N; Thomsen MK
    Nat Commun; 2024 Mar; 15(1):2088. PubMed ID: 38453924
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer.
    Lee JY; Bhandare RR; Boddu SHS; Shaik AB; Saktivel LP; Gupta G; Negi P; Barakat M; Singh SK; Dua K; Chellappan DK
    Biomed Pharmacother; 2024 Apr; 173():116275. PubMed ID: 38394846
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Extracellular Vesicles Obtained From lung Adenocarcinoma Cells Cultured Under Intermittent Hypoxia Induce M2 Macrophage Polarization via miR-20a-5p Delivery.
    Liu Y; Lu M; Liu F; Xu G; Feng C; Chen Y; Cai D; Sun H; Zeng Y; Xie J; Ma W; Gao X
    Technol Cancer Res Treat; 2024; 23():15330338231219415. PubMed ID: 38327167
    [No Abstract]    [Full Text] [Related]  

  • 10. Macrophage-derived exosomal microRNAs promote metastasis in pancreatic ductal adenocarcinoma.
    Chen Y; Lei Y; Li J; Wang X; Li G
    Int Immunopharmacol; 2024 Mar; 129():111590. PubMed ID: 38316083
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Unraveling EGFR-TKI resistance in lung cancer with high PD-L1 or TMB in EGFR-sensitive mutations.
    Ding W; Yang P; Zhao X; Wang X; Liu H; Su Q; Wang X; Li J; Gong Z; Zhang D; Wang X
    Respir Res; 2024 Jan; 25(1):40. PubMed ID: 38238740
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Coexpression of TP53, BIM, and pten Enhances the Therapeutic Efficacy of Non-Small-Cell lung cancer.
    Lu L; Ma D; Xi Z
    Biomacromolecules; 2024 Feb; 25(2):792-808. PubMed ID: 38237562
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical-Molecular characteristics and Post-Translational modifications of colorectal cancer in north China: Implications for future targeted therapies.
    Chi Y; Yuan H; Fan Q; Wang Z; Niu Z; Yu J; Yuan D
    Gene; 2024 Mar; 899():148134. PubMed ID: 38185290
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
    Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
    Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Integrative analysis of transcriptomic and metabolomic profiles reveals enhanced arginine metabolism in androgen-independent prostate cancer cells.
    Dai X; Shi X; Luo M; Li P; Gao Y
    BMC Cancer; 2023 Dec; 23(1):1241. PubMed ID: 38104097
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Active Gα
    Lyu C; Bhimani AK; Draus WT; Weigel R; Chen S
    Mol Cell Biol; 2023; 43(12):650-663. PubMed ID: 38099640
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Diagnostic Utility of Next-Generation Sequencing in Circulating Free DNA and a Comparison With Matched Tissue in Gallbladder Carcinoma.
    Mishra S; Srivastava P; Pandey A; Shukla S; Agarwal A; Husain N
    Lab Invest; 2024 Feb; 104(2):100301. PubMed ID: 38092180
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CRISPR Screening Identifies Mechanisms of Resistance to KRASG12C and SHP2 Inhibitor Combinations in Non-Small Cell lung cancer.
    Prahallad A; Weiss A; Voshol H; Kerr G; Sprouffske K; Yuan T; Ruddy D; Meistertzheim M; Kazic-Legueux M; Kottarathil T; Piquet M; Cao Y; Martinuzzi-Duboc L; Buhles A; Adler F; Mannino S; Tordella L; Sansregret L; Maira SM; Graus Porta D; Fedele C; Brachmann SM
    Cancer Res; 2023 Dec; 83(24):4130-4141. PubMed ID: 37934115
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cisplatin-activated ERβ/DCAF8 positive feedback loop induces chemoresistance in non-small cell lung cancer via pten/Akt axis.
    Hu Y; Xu Y; Zhang T; Han Q; Li L; Liu M; Li N; Shao G
    Drug Resist Updat; 2023 Nov; 71():101014. PubMed ID: 37913652
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comparison of immunohistochemistry and next-generation sequencing results in oncogenic pten missense mutations.
    Kim M; Kim J; Seo AN; Jeong JY; Park NJ; Chong GO; Hong DG; Park JY
    Pathol Res Pract; 2023 Nov; 251():154879. PubMed ID: 37862920
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 53.